Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week